MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18
Open accessThe DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.
Abstract
Signaling through the adaptor protein myeloid differentiation factor 88 (MyD88) promotes carcinogenesis in several cancer models. In contrast, MyD88 signaling has a protective role in the development of azoxymethane (AOM)/dextran sodium sulfate (DSS) colitis-associated cancer (CAC). The inability of Myd88(-/-) mice to heal ulcers generated upon injury creates an altered inflammatory environment that induces early alterations in expression of genes encoding proinflammatory factors, as well as pathways regulating cell proliferation, apoptosis, and DNA repair, resulting in a dramatic increase in adenoma formation and progression to infiltrating adenocarcinomas with frequent clonal mutations in the beta-catenin gene. Others have reported that toll-like receptor (Tlr) 4-deficient mice have a similar susceptibility to colitis to Myd88-deficient mice but, unlike the latter, are resistant to CAC. We have observed that mice deficient for Tlr2 or Il1r do not show a differential susceptibility to colitis or CAC. However, upon AOM/DSS treatment Il18(-/-) and Il18r1(-/-) mice were more susceptible to colitis and polyp formation than wild-type mice, suggesting that the phenotype of Myd88(-/-) mice is, in part, a result of their inability to signal through the IL-18 receptor. This study revealed a previously unknown level of complexity surrounding MyD88 activities downstream of different receptors that impact tissue homeostasis and carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, IL-18 KO or IL-18R KO mice are also highly sensitive to colitis-associated CRC [124,125].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [125]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383 · cited 4×
“We observed enhanced expression of several known STAT3-dependent genes (Yu et al., 2009) in addition to Il6 and Il11 in AOM/DSS-treated Myd88/ mice, including Cox2, Hif1a, and several metalloproteases.”
BackgroundInfluentialRecognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251 · cited 2×
“RESULTS Myd88/ mice show increased susceptibility to develop colonic tumors after AOM/DSS administration Myd88/ mice are highly susceptible to the development of colitis induced by irradiation or DSS as a result of reduced ability to repair the mucosal integrity after injury with significant morbidity and mortalit…”
BackgroundIKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155 · cited 2×
“STAT3 activation in both epithelial cells and in stromal and infiltrating cells has been shown to regulate the tumor inflammatory environment as well as to have direct effects on the tumor itself by inducing antiapoptotic, proangiogenic, and proproliferative gene expression programs (Grivennikov et al., 2009; Yu et al…”
BackgroundSystematic variation in gene expression patterns in human cancer cell lines
Ross, D. T., Scherf, U., Eisen, M. B., Perou, C. M., Rees, C., Spellman, P., Iyer, V., Jeffrey, S. S., Van de Rijn, M., Waltham, M., et al. (2000) · Nature Genetics · doi:10.1038/73432 · Cited by 2,088
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
Landon, M., Saam, J., Brown, K. L., Moyes, K., Evans, B., & Wenstrup, R. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,939
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617 · cited 2×
“…and Il18/ mice to colon carcinogenesis might exclusively be the result of the lack of an immunosurveillance effect of adaptive immunity and IFN- (Dunn et al., 2006), particularly when it is considered that Rag/ immunodeficient mice have reduced rather than increased susceptibility to colon…”
BackgroundStabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines
Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E., & Polakis, P. (1997) · Science · doi:10.1126/science.275.5307.1790 · Cited by 1,223
Cited by
Items 201–300 of 451
Epithelial regulation of microbiota-immune cell dynamics
Didriksen, B. J., Eshleman, E. M., & Alenghat, T. (2024) · Mucosal Immunology · doi:10.1016/j.mucimm.2024.02.008 · Cited by 56
Gagliani, N., Palm, N. W., de Zoete, M. R., & Flavell, R. A. (2014) · International Immunology · doi:10.1093/intimm/dxu066 · Cited by 54
Inflammasome in Intestinal Inflammation and Cancer
Nunes, T., & de Souza, H. S. P. (2013) · Mediators of Inflammation · doi:10.1155/2013/654963 · Cited by 56
“Of note, IL-18 usesMyD88 as a downstream signal transduction effector and MyD88 signaling has been shown to have a protective role in the development of AOM/DSS colitis [8].”
BackgroundInfluentialDifferential role of MyD88 and Mal/TIRAP in TLR2-mediated gastric tumourigenesis
Kennedy, C. L., Najdovska, M., Tye, H., McLeod, L., Yu, L., Jarnicki, A., Bhathal, P. S., Putoczki, T. L., Ernst, M., & Jenkins, B. J. (2013) · Oncogene · doi:10.1038/onc.2013.205 · Cited by 53
Caspase-11 attenuates gastrointestinal inflammation and experimental colitis pathogenesis
Williams, T. M., Leeth, R. A., Rothschild, D. E., McDaniel, D. K., Coutermarsh‐Ott, S. L., Simmons, A., Kable, K. H., Heid, B., & Allen, I. C. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00234.2014 · Cited by 57
“It should be noted that both increased and attenuated levels of IL-1 and IL-18 have been shown to significantly influence IBD pathogenesis (6, 18, 44, 47).”
BackgroundResultJauch, D., Martin, M., Schiechl, G., Kesselring, R., Schlitt, H. J., Geissler, E. K., & Fichtner‐Feigl, S. (2011) · Gut · doi:10.1136/gutjnl-2011-300612 · Cited by 55
“In accordance with the hypothesis that IL-18 might initiate a tumour-suppressive Th1-based microenvironment, recent work from Salcedo et al has shown that IL-18-deficient mice have a much higher tumour burden than wild-type mice during chronic DSS-colitis with AOM-induced tumour formation.(7) However, additional resea…”
BackgroundIL-18/IL-18BP and IL-22/IL-22BP: Two interrelated couples with therapeutic potential
Mühl, H., & Bachmann, M. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109388 · Cited by 53
NLRP3 inflammasome-induced pyroptosis in digestive system tumors
Wen, J., Xuan, B., Liu, Y., Wang, L., He, L., Meng, X., Zhou, T., & Wang, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1074606 · Cited by 53
Jiang, Q., Jiang, Z., Jones‐Hall, Y., Jang, Y., Snyder, P. W., Bain, C., Huang, J., Jannasch, A., Cooper, B. R., Wang, Y., et al. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.08.187 · Cited by 59
“The colon sections from DSS study 2 were assessed in a blind fashion by a board certified veterinary pathologist for inflammation and tissue damage using a semiquantitative scoring system (0–12) [31]: Severity of inflammation: 0 = none, 1 = mild, 2 = moderate and 3 = severe; Extent of inflammation: 0 = none, 1 = focal…”
MethodThe Cdx2 homeobox gene suppresses intestinal tumorigenesis through non–cell-autonomous mechanisms
Balbinot, C., Armant, O., Elarouci, N., Marisa, L., Martin, E., Clara, E. D., Onéa, A., Deschamps, J., Beck, F., Freund, J., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20170934 · Cited by 56
“…Chun et al., 2015; Zhang et al., 2015), and IL6 family members (IL6, IL11, Osm, and Lif, considered potent drivers of cancer progression; Putoczki et al., 2013) were increased, whereas IL15 and IL18 (with anticancer activity; Salcedo et al., 2010; Bahri et al., 2015) were decreased.”
BackgroundHu, B., Elinav, E., & Flavell, R. A. (2011) · Cell Cycle · doi:10.4161/cc.10.12.16008 · Cited by 53
Messaritakis, I., Stogiannitsi, M., Koulouridi, A., Sfakianaki, M., Voutsina, A., Sotiriou, A., Athanasakis, E., Xynos, E., Mavroudis, D., Tzardi, M. N., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197327 · Cited by 52
Inflammatory cell death in intestinal pathologies
Sharma, D., & Kanneganti, T. (2017) · Immunological Reviews · doi:10.1111/imr.12602 · Cited by 51
Innate Sensing through Mesenchymal TLR4/MyD88 Signals Promotes Spontaneous Intestinal Tumorigenesis
Koliaraki, V., Chalkidi, N., Henriques, A. R., Tzaferis, C., Polykratis, A., Waisman, A., Müller, W., Hackam, D. J., Pasparakis, M., & Kollias, G. A. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.072 · Cited by 52
Tumor-Associated Inflammation: The Tumor-Promoting Immunity in the Early Stages of Tumorigenesis
Bi, Q., Wu, J., Qiu, X., Zhang, J., Sun, Z., & Wang, W. (2022) · Journal of Immunology Research · doi:10.1155/2022/3128933 · Cited by 52
“However, in contrast, deleting the Aim2 [129], Asc [129, 130], Nlrp3 [131, 132], Nlrc4 [133], Casp1 [132, 133], or Il-18r [134] genes invariably exacerbated the burden of AOM/DSS-induced colorectal cancer in mice.”
Interaction between microbiota and immunity and its implication in colorectal cancer
Xing, C., Du, Y., Duan, T., Nim, K., Chu, J., Wang, H. Y., & Wang, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.963819 · Cited by 52
Microbiota and innate immunity in intestinal inflammation and neoplasia
Cario, E. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835a670e · Cited by 46
“Mice lacking MyD88, the common adaptor for TLR/IL-1R/ IL-18R signal transduction, are highly susceptible to developing colitis-associated tumors in the murine azoxymethane (AOM)/dextran sodium sulfate (DSS) model, possibly due to their inability to signal through the IL-18R [36].”
BackgroundRole of Inflammation in Pathophysiology of Colonic Disease: An Update
Nasef, N. A., & Mehta, S. Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134748 · Cited by 49
Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases
Vong, C. T., Tseng, H. H. L., Yao, P., Yu, H., Wang, S., Zhong, Z., & Wang, Y. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.02.018 · Cited by 51
NLRP6 in infection and inflammation
Anand, P. K., & Kanneganti, T. (2013) · Microbes and Infection · doi:10.1016/j.micinf.2013.06.009 · Cited by 47
“Apparently, this can be explained by the fact that IL-18 protects against intestinal damage by maintaining epithelial barrier integrity [40, 41].”
BackgroundCancer in inflammatory bowel disease: lessons from animal models
Sussman, D. A., Santaolalla, R., Strobel, S., Dheer, R., & Abreu, M. T. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328354cc36 · Cited by 52
Sípos, F., Fűri, I., Constantinovits, M., Tulassay, Z., & Műzes, G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i36.12713 · Cited by 45
Nod1 Limits Colitis-Associated Tumorigenesis by Regulating IFN-γ Production
Zhan, Y., Seregin, S. S., Chen, J., & Chen, G. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501822 · Cited by 44
IRAK4 mediates colitis-induced tumorigenesis and chemoresistance in colorectal cancer
Li, Q., Chen, Y., Zhang, D., Grossman, J. G., Li, L., Khurana, N., Jiang, H., Grierson, P. M., Herndon, J. M., DeNardo, D. G., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.130867 · Cited by 43
“As opposed to the MyD88–/–APCMin/+ model, MyD88–/– C57BL/6 mice develop more severe colitis upon acute AOM and/or DSS treatment, leading to more DNA damage and higher incidence of CRC development (50, 53, 54).”
ResultThe Mycobiome: Cancer Pathogenesis, Diagnosis, and Therapy
Gamal, A., Elshaer, M. Y. S., Alabdely, M. H., Kadry, A., McCormick, T. S., & Ghannoum, M. A. (2022) · Cancers · doi:10.3390/cancers14122875 · Cited by 45
“This in turn altered the inflammatory environment, exacerbating the mutation rate of mucosal epithelial cells, and consequently increasing adenoma formation and cancer progression [40].”
BackgroundLuddy, K. A., Robertson‐Tessi, M., Tafreshi, N. K., Soliman, H. H., & Morse, D. L. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00429 · Cited by 46
Liu, M., Hu, Z., Wang, C., & Zhang, Y. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02332-5 · Cited by 45
Banerjee, A., Thamphiwatana, S., Carmona, E. M., Rickman, B. H., Doran, K. S., & Obonyo, M. (2013) · Infection and Immunity · doi:10.1128/iai.01344-13 · Cited by 46
“Studies using inflammation-associated cancer models have reported opposing effects of MyD88 in carcinogenesis with protumor effects in liver (9), colorectal (10), and skin (11) cancers and antitumor effects in pancreatic (12) and colon (13) cancers.”
BackgroundResultHradická, P., Beal, J., Kassayová, M., Foey, A., & Demečková, V. (2020) · Microorganisms · doi:10.3390/microorganisms8030387 · Cited by 43
“…is crucial for intestinal epithelial cells’ (IECs) homeostasis and mucosal repair, inducing IEC proliferation / di ff erentiation, goblet cell mucus production, the expression of tight junction proteins and secretion of anti-bacterial peptides [51,52] essential in preventing CRC development [53].”
BackgroundInterleukin 1β—A Potential Salivary Biomarker for Cancer Progression?
Idris, A., Ghazali, N. B., & Koh, D. S. Q. (2015) · Biomarkers in Cancer · doi:10.4137/bic.s25375 · Cited by 50
Inflammasomes in Colitis and Colorectal Cancer: Mechanism of Action and Therapies.
Pandey, A., Shen, C. X., & Man, S. M. (2019) · Europe PMC (PubMed Central) · Cited by 53
Ghaleb, A. M., Bialkowska, A. B., Snider, A. J., Gnatenko, D. V., Hannun, Y. A., Yang, V. W., & Schmidt, V. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129314 · Cited by 41
“It was shown that azoxymethane (AOM)-DSS-induced colitis triggered up-regulation of Iqgap2 expression inMyD88 colons and not in the similarly treated WT controls [49] (S1 Table), suggesting that MyD88 or its downstream effectors may negatively regulate IQGAP2 expression.”
BackgroundTartey, S., Neale, G. A. M., Vogel, P., Malireddi, R. K. S., & Kanneganti, T. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3510 · Cited by 40
“MyD88 was also found to prevent lesion formation in a mouse model of colitis-associated cancer as a result of altered colonic homeostasis (19).”
BackgroundTRIF Signaling Drives Homeostatic Intestinal Epithelial Antimicrobial Peptide Expression
Stockinger, S., Duerr, C. U., Fulde, M., Dolowschiak, T., Pott, J., Yang, I., Eibach, D., Bäckhed, F., Akira, S., Suerbaum, S., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302708 · Cited by 44
Src-family kinase-Cbl axis negatively regulates NLRP3 inflammasome activation
Chung, I., Yuan, S.-N., OuYang, C., Lin, H., Huang, K., Chen, Y.-J., Chung, A., Chu, C., Ojcius, D. M., Chang, Y., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1163-z · Cited by 38
Effector functions of NLRs in the intestine: innate sensing, cell death, and disease
Yeretssian, G. (2012) · Immunologic Research · doi:10.1007/s12026-012-8317-3 · Cited by 37
Petralia, M. C., Mazzon, E., Fagone, P., Falzone, L., Bramanti, P., Nicoletti, F., & Basile, M. S. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7774 · Cited by 38
RNase-L Deficiency Exacerbates Experimental Colitis and Colitis-associated Cancer
Long, T. M., Chakrabarti, A., Ezelle, H. J., Brennan-Laun, S. E., Raufman, J., Polyakova, I. V., Silverman, R. H., & Hassel, B. A. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281f2fd · Cited by 38
“The increased sensitivity to DSS-induced colitis observed in mice lacking mediators of GI homeostasis is associated with enhanced susceptibility to colitis-associated cancer induced by DSS/AOM.(9,13,16) Similarly, DSS/AOM treatment resulted in an increased tumor burden in RNase-L2/2 as compared with WT mice (Fig.”
BackgroundRegulation of the gut microbiome by inflammasomes
Chen, G. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.11.011 · Cited by 38
Lozenov, S., Krastev, B. M., Nikolaev, G., Peshevska-Sekulovska, M., Peruhova, M., & Velikova, T. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065978 · Cited by 36
“Butyrate also has an affinity to GPR109A, which is how this metabolite stimulates the production of IL-18, a cytokine with a defined role in preventing the development of colon tumors [61].”
BackgroundColorectal cancer, radiotherapy and gut microbiota
Zhang, S., Wang, Q., Zhou, C., Chen, K., Chang, H., Xiao, W., & Gao, Y. (2019) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2019.01.16 · Cited by 36
Frühbeck, G., Gómez‐Ambrosi, J., Ramírez, B., Becerril, S., Rodríguez, A., Mentxaka, A., Valentí, V., Moncada, R., Reina, G., Baixauli, J., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05124-3 · Cited by 37
Gastrointestinal microbiota and inflammasomes interplay in health and disease: a gut feeling
Luca, R. D., Arrè, V., Nardone, S., Incerpi, S., Giannelli, G., Trivedi, P., Anastasiadou, E., & Negro, R. (2025) · Gut · doi:10.1136/gutjnl-2025-334938 · Cited by 37
“In particular, bioavailable IL-18 cytokine promotes epithelial barrier regeneration during colitis-associated cancer 81 82 and coordinates NK cell-mediated and T cell-mediated antitumour immune responses.”
IL-22 Signaling in the Tumor Microenvironment
Jiang, R., & Sun, B. (2021) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-55617-4_5 · Cited by 35
MyD88 and Its Inhibitors in Cancer: Prospects and Challenges
Song, J., Li, Y., Wu, K., Hu, Y., & Fang, L. (2024) · Biomolecules · doi:10.3390/biom14050562 · Cited by 37
“Several studies have shown that MyD88-mediated signal transduction plays a key role in promoting tumor development and progression [11,12].”
BackgroundFlood, B., Manils, J., Nulty, C., Flis, E., Kenealy, S., Barber, G. L., Fay, J., Mills, K. H. G., Kay, E. W., & Creagh, E. M. (2018) · Oncogene · doi:10.1038/s41388-018-0613-5 · Cited by 34
Dual Role of TNF and LTα in Carcinogenesis as Implicated by Studies in Mice
Gubernatorova, E. O., Polinova, A. I., Petropavlovskiy, M., Namakanova, O. A., Medvedovskaya, A. D., Zvartsev, R. V., Telegin, G. B., Drutskaya, M. S., & Nedospasov, S. A. (2021) · Cancers · doi:10.3390/cancers13081775 · Cited by 34
“In the mouse model of AOM/DSS-induced colorectal cancer, MyD88-deficiency resulted in increased tumor growth [145], suggesting that signaling downstream of Toll-like receptors may provide protection from colon tumors [146].”
BackgroundImmune reaction and colorectal cancer: Friends or foes?
Formica, V., Cereda, V., Nardecchia, A., Tesauro, M., & Roselli, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i35.12407 · Cited by 36
The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers
Gouravani, M., Khalili, N., Razi, S., Keshavarz‐Fathi, M., Khalili, N., & Rezaei, N. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1713755 · Cited by 35
“Colitisassociated colon cancer IL-18 mice show boosted inflammation and carcinogenesis in an AOM/DSS model IL-18 secreted from intestinal epithelial cells is crucial for intestinal tissue repair and epithelial cell regeneration Impaired production of the tumor suppressors; IFN-gamma and STAT1 [73,100]”
BackgroundMatamoros, J. A., da Silva, M. I. F., de Moura, P. M. M. F., Leitão, M. D. C. G., & Coimbra, E. C. (2019) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2019.20.9.2715 · Cited by 39
“In addition, there is a reduced activity and immune capacity in the IL-18 -/- NK cells, and it has been reported that IL-18-deficient mice develop a greater inflammatory response and cancerous lesions in the intestinal epithelium (Salcedo et al., 2010).”
BackgroundIyer, K., Erkert, L., & Becker, C. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1228283 · Cited by 34
“MyD88 mouse models show variable responses to carcinoma challenge, depending on the differential inflammation in the models (Uronis et al., 2009; Salcedo et al., 2010; Schiechl et al., 2011).”
BackgroundThe Inflammasome: Regulation of Nitric Oxide and Antimicrobial Host Defence
Ramachandran, R. A., Lupfer, C. R., & Zaki, H. (2018) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2018.01.004 · Cited by 33
Mladenova, D. N., & Kohonen‐Corish, M. R. J. (2012) · PubMed · Cited by 38
Microbial recognition regulates intestinal epithelial growth in homeostasis and disease
Ferguson, M., & Foley, E. (2021) · FEBS Journal · doi:10.1111/febs.15910 · Cited by 31
Insights into the role of the intestinal microbiota in colon cancer
Oke, S., & Martín, A. (2017) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x17694832 · Cited by 38
Innate inflammation and cancer: Is it time for cancer prevention?
Trinchieri, G. (2011) · F1000 Medicine Reports · doi:10.3410/m3-11 · Cited by 32
Self-citationMiR-223-3p attenuates the migration and invasion of NSCLC cells by regulating NLRP3
Zhu, S., Kong, X., Song, M., Chi, M., Liu, Y., Zhang, P., Zhang, Q., Shang, P., & Feng, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.985962 · Cited by 35
Role of programmed necrosis and cell death in intestinal inflammation
Dagenais, M., Douglas, T., & Saleh, M. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000117 · Cited by 32
The Impact of the Gut Microbiome on Colorectal Cancer
Maisonneuve, C., Irrazábal, T., Martín, A., Girardin, S. E., & Philpott, D. J. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050240 · Cited by 31
“However, Tlr2 and MyD88 signaling also protects mice from CAC (Lowe et al. 2010, Salcedo et al. 2010).”
BackgroundLee, H.-J., Park, J., Han, Y. M., Gil, H. K., Kim, J.-H., Chang, J. Y., Jeong, M., Go, E., & Hahm, K. B. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1103179 · Cited by 29
“[69] showed that IL-18 signaling protects against tissue damage in DSS-induced colitis and DSS plus AOMinduced CAC in animal models.”
BackgroundJala, V. R., Maturu, P., Bodduluri, S. R., Krishnan, E., Mathis, S., Subbarao, K., Wang, M., Jenson, A. B., Proctor, M., Rouchka, E. C., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1361593 · Cited by 29
“colon tumor model significantly increased the colon tumor burden.(72) However, it is possible that extensive breach in the intes-”
BackgroundNLRC4, inflammation and colorectal cancer (Review)
Tong, G., Shen, Y., Li, H., Qian, H., & Tan, Z. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5687 · Cited by 28
Li, J., Qin, X., Shi, J., Wang, X., Li, T., Xu, M., Chen, X., Zhao, Y., Han, J., Piao, Y., et al. (2021) · eLife · doi:10.7554/elife.66222 · Cited by 30
Steinmann, S. M., Koop, K., Erlenbach‐Wuensch, K., Neufert, C. F., & Schneider‐Stock, R. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2998 · Cited by 29
Lozano‐Pope, I., Sharma, A., Matthias, M. A., Doran, K. S., & Obonyo, M. (2017) · BMC Cancer · doi:10.1186/s12885-017-3114-y · Cited by 29
Dacrema, M., Ali, A., Ullah, H., Khan, A., Minno, A. D., Xiao, J., Martins, A. M. C., & Daglia, M. (2022) · Cancers · doi:10.3390/cancers14225682 · Cited by 31
Zeng, Q., Fu, J. L., Korrer, M. J., Gorbounov, M., Murray, P. J., Pardoll, D., Masica, D. L., & Kim, Y. J. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0543 · Cited by 28
“dependent neoplastic development in some of these murine models (28, 29).”
BackgroundJennemann, R., Volz, M., Bestvater, F., Schmidt, C., Richter, K., Kaden, S., Müthing, J., Gröne, H., & Sandhoff, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910539 · Cited by 26
Sinkovics, J. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1248 · Cited by 28
Immunotherapeutic Applications of IL-18
Tsutsui, H., & Nakanishi, K. (2012) · Immunotherapy · doi:10.2217/imt.12.137 · Cited by 25
Liu, B., Yan, S., Jia, Y., Ma, J., Wu, S., Xu, Y., Mingyi, S., & Mao, A. (2016) · FEBS Journal · doi:10.1111/febs.13894 · Cited by 27
Aviello, G., Corr, S. C., Johnston, D. G. W., O'Neill, L. A. J., & Fallon, P. G. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00399.2013 · Cited by 30
“On the other hand, MyD88-deficient mice are highly susceptible to the development of colonic inflammation (2, 37) and cancer (39), with innate MyD88 rather than an epithelial cell MyD88 signal having a pivotal role in the development of chronic intestinal inflammation (5).”
BackgroundDietary fiber as a wide pillar of colorectal cancer prevention and adjuvant therapy
Pedrosa, L. D. F., & Fabi, J. P. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2164245 · Cited by 24
“…models, Myd88−/− mice treated with azoxymethane and dextran sulfate sodium (DSS) developed more polyps related to colonic inflammation, while having alterations in gene expression related to DNA repair and cell proliferation, resulting in a higher prevalence of adenomas (Salcedo et al. 2010).”
BackgroundHan, Y., Park, J., Cha, J.-Y., Jeong, M., Go, E., & Hahm, K. B. (2015) · International Journal of Cancer · doi:10.1002/ijc.29956 · Cited by 24
Inoue, N., Li, W., Fujimoto, Y., Matsushita, Y., Katagiri, T., Okamura, H., & Miyoshi, Y. (2019) · Anticancer Research · doi:10.21873/anticanres.13691 · Cited by 26
Dagenais, M., Dupaul-Chicoine, J., Champagne, C., Skeldon, A. M., Morizot, A., & Saleh, M. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.46 · Cited by 26
Inflammatory Bowel Diseases and Inflammasome
Kim, J. M. (2011) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2011.58.6.300 · Cited by 24
“또한 AOM/DSS를 처리한 IL18 IL18r1 마우스는 정상 마우스보다 장폴립(intestinal polyp) 의 숫자가 증가되었다.(102) 이와 같은 결과들은 CAC 발생을 억제할 수 있는 기전으로써, NLRP3 inflammasome 신호전”
Immunomodulation by Gut Microbiome on Gastrointestinal Cancers: Focusing on Colorectal Cancer
AL-Ishaq, R. K., Koklesová, L., Kubatka, P., & Büsselberg, D. (2022) · Cancers · doi:10.3390/cancers14092140 · Cited by 24
Boonyaleka, K., Okano, T., Iida, T., Leewananthawet, A., Sasai, M., Yamamoto, M., Ashida, H., & Suzuki, T. (2023) · European Journal of Immunology · doi:10.1002/eji.202350455 · Cited by 23
“Loss of IL-18 enhances the damage to the intestinal epithelium, and IL-18 signaling supports intestinal integrity and decreases susceptibility to colitis and CRC [17].”
BackgroundColorectal cancer mouse models: Integrating inflammation and the stroma
Ernst, M., & Ramsay, R. G. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06883.x · Cited by 24
Mutation and expression analysis of the IDH1, IDH2, DNMT3A, and MYD88 genes in colorectal cancer
Li, W., Xiao, M., Zhang, D., Yu, D., Yang, R., Li, X., & Yao, Y. (2014) · Gene · doi:10.1016/j.gene.2014.05.070 · Cited by 25
Aghbash, P. S., Rasizadeh, R., Nahand, J. S., & Baghi, H. B. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113625 · Cited by 25
Garg, S., Sharma, N., Bharmjeet, & Das, A. (2023) · Cancer Reports · doi:10.1002/cnr2.1892 · Cited by 27
“59,66 Through the downregulation of pro-inflammatory IL-22 and promotion of epithelial damage repair, the protective IL-18 pathway, which is controlled by the MYD88 protein, confers a protective character to the colonic epithelium.”
BackgroundRodent Intestinal Epithelial Carcinogenesis: Pathology and Preclinical Models
Ward, J. M., & Treuting, P. M. (2013) · Toxicologic Pathology · doi:10.1177/0192623313505156 · Cited by 25
Wendlinger, S., Wohlfarth, J., Kreft, S., Siedel, C., Kilian, T., Dischinger, U., Heppt, M. V., Wistuba‐Hamprecht, K., Meier, F. E., Goebeler, M., et al. (2022) · Cancers · doi:10.3390/cancers14092294 · Cited by 23
“Neutralization of CD18 abolished the beneficial inhibition of tumor growth in vitro in Colo-205 and in the colons of mice [18,58].”
BackgroundThe Role of IL-18 in P2RX7-Mediated Antitumor Immunity
Hreich, S. J. D., Hofman, P. M., & Vouret‐Craviari, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119235 · Cited by 21
“Indeed, there is an absence of the components of the NLRP3 inflammasome, IL-18 exacerbated cancer progression [97] and inflammatory markers [98].”
BackgroundHou, J., Li, T., Hsu, J.-M., Zhang, X., & Hung, M. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101833 · Cited by 21
Ramírez-Pérez, S., Vekariya, R., Gautam, S., Reyes‐Pérez, I. V., Drissi, H., & Bhattaram, P. (2023) · Arthritis Research & Therapy · doi:10.1186/s13075-023-03145-0 · Cited by 21
“[48], osteosarcoma [49], adenocarcinoma of the colon [50], and hematopoietic cancer-like lymphoma and leukemia [45].”
BackgroundImmunotherapeutic Approach for Better Management of Cancer - Role of IL-18
Kuppala, M. B., Syed, S. B., Bandaru, S., Varre, S., Jyothy, A., & Mundulru, H. P. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.11.5353 · Cited by 23
Prognostic Role of Inflammasome Components in Human Colorectal Cancer
Domblides, C., Soubeyran, I., Lartigue, L., Mahouche, I., Lefort, F., Velasco, V., Barnetche, T., Blanco, P., Déchanet‐Merville, J., & Faustin, B. (2020) · Cancers · doi:10.3390/cancers12123500 · Cited by 20
“Indeed, IL-18-/- mice show an increased incidence of polyps, colitis and colorectal cancers [14], therefore illustrating its role in cancer protection under steady state conditions.”
BackgroundMacrophage orchestration of epithelial and stromal cell homeostasis in the intestine
Cao, Q., Mertens, R. T., Sivanathan, K. N., Cai, X., & Xiao, P. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ru0322-176r · Cited by 21
Inflammasomes and intestinal tumorigenesis
Zaki, H., Lamkanfi, M., & Kanneganti, T. (2011) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2011.11.003 · Cited by 21
“Given that STAT3 phosphorylation is increased in MyD88-deficient and IL-18– deficient mouse colonic epithelial cells during AOM+DSS–induced colitis [39], it appears likely that inflammasomes may regulate tumorigenesis by limiting STAT3 phosphorylation (Fig.”
BackgroundInfluentialRole of IL-18 induced Amphiregulin expression on virus induced ocular lesions
Varanasi, S. K., Rajasagi, N. K., Jaggi, U., & Rouse, B. T. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0058-8 · Cited by 21
Dietary Patterns and Associated Microbiome Changes that Promote Oncogenesis
Ibragimova, S., Ramachandran, R., Ali, F. R., Lipovich, L., & Ho, S. B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.725821 · Cited by 19
“Moreover, apart from inhibiting the production of RASA1, miR21 also downregulates Pdcd4, which is a key tumor suppressor (Yang et al., 2017a).”
BackgroundInfluentialChen, T., Gu, K., Lin, R., Liu, Y., & Shan, Y. (2022) · Bioengineered · doi:10.1080/21655979.2022.2076500 · Cited by 19
“However, recently, several researches reveal that mice with IL-18 or IL-18 R knockout are more sensitive, rather than resistant, to dextran sulfate sodium (DSS)-induced enteritis and inflammatory bowel cancer [11].”
BackgroundRetractedYang, W. S., Kim, H. G., Kim, E., Han, S. Y., Aziz, N., Yi, Y., Kim, S.-G., Lee, Y., Yoo, B. C., Han, J., et al. (2020) · Cells · doi:10.3390/cells9051216 · Cited by 19
“Finally, since functional role of MyD88 or TRIF in inflammatory responses is cell-type specific in DSS-induced colitis and colorectal cancer models [82,83], therefore, we will also dissect functional involvement of ICMT/Ras pathway with different cells (e.”
BackgroundDouble-edged sword of inflammasome genetics in colorectal cancer prognosis
Cambui, R. A. G., Santo, G. F. D. E., Fernandes, F. P., Leal, V. N. C., Galera, B. B., Favaro, E. G. P., Rizzo, L. A., Elias, R. M., & Pontillo, A. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108373 · Cited by 19
Liu, Q., Lee, J. H., Kang, H. M., & Kim, C. H. (2022) · Science Advances · doi:10.1126/sciadv.abq1551 · Cited by 20
Toll-Interacting Protein Regulates Immune Cell Infiltration and Promotes Colitis-Associated Cancer
Begka, C., Pattaroni, C., Mooser, C., Nancey, S., McCoy, K. D., Velin, D., & Maillard, M. H. (2020) · iScience · doi:10.1016/j.isci.2020.100891 · Cited by 18
Commensal-Innate Immune Miscommunication in IBD Pathogenesis
Cario, E. (2012) · Digestive Diseases · doi:10.1159/000338120 · Cited by 18
Metadata
- Authors
- Salcedo, R., Worschech, A., Cardone, M., Jones, Y., Gyulai, Z., Dai, R.-M., Wang, E., Ma, W., Haines, D., O'hUigin, C., Marincola, F. M., & Trinchieri, G.
- Affiliations
- National Cancer Institute (US)
- National Institutes of Health (US)
- Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21701 1
- Science Applications International Corporation (United States) (US)
- Corresponding author
- Trinchieri, Giorgio
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-07-12
- Volume
- 207
- Issue
- 8
- Pages
- 1625-1636
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2916129
- OpenAlex
- W2118983602
- Cited by
- 429
- References
- 44
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 10 · 2023: 24 · 2022: 21 · 2021: 24 · 2020: 26 · 2019: 21 · 2018: 38 · 2017: 38 · 2016: 18 · 2015: 35 · 2014: 36 · 2013: 42 · 2012: 37
- FWCI
- 16.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (HHSN261200800001C)
- National Cancer Institute (HHSN261200800001E))
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- MyD88 signaling, IL-18, interleukin-18 receptor, colitis-associated colorectal cancer, colon adenocarcinoma, carcinogenesis, inflammatory bowel disease, CTNNB1 mutation, adenoma formation, MyD88-deficient mice, TLR2, TLR4, tissue homeostasis
- MeSH terms
- Adenocarcinoma, Animals, Azoxymethane, Colon, Colonic Neoplasms, Colonic Polyps, Epithelial Cells, Intestinal Mucosa, Mice, Inbred C57BL, Mutation, Phosphorylation, Specific Pathogen-Free Organisms, Inflammatory Bowel Diseases, Signal Transduction, Gene Expression, Dextran Sulfate, Apoptosis, Mice, Knockout, Genetic Predisposition to Disease, Interleukin-18, Gene Expression Profiling, DNA Repair Enzymes, Cell Proliferation, STAT3 Transcription Factor, beta Catenin, Mice, Cyclooxygenase 2, Receptors, Interleukin-1 Type I, Myeloid Differentiation Factor 88, Interleukin-18 Receptor alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.